Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification-Reference-Cited by-同舟云学术

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Published:2015-05-22 Issue:1 Volume:16 Page:
ISSN:1474-760X
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

Ng Charlotte KY,Martelotto Luciano G,Gauthier Arnaud,Wen Huei-Chi,Piscuoglio Salvatore,Lim Raymond S,Cowell Catherine F,Wilkerson Paul M,Wai Patty,Rodrigues Daniel N,Arnould Laurent,Geyer Felipe C,Bromberg Silvio E,Lacroix-Triki Magali,Penault-Llorca Frederique,Giard Sylvia,Sastre-Garau Xavier,Natrajan Rachael,Norton Larry,Cottu Paul H,Weigelt Britta,Vincent-Salomon Anne,Reis-Filho Jorge S

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13059-015-0657-6.pdf

Reference65 articles.

1. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997–4013.

2. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4:177–83.

3. Shiu KK, Natrajan R, Geyer FC, Ashworth A, Reis-Filho JS. DNA amplifications in breast cancer: genotypic-phenotypic correlations. Future Oncol. 2010;6:967–84.

4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177–82.

5. Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer. 2007;7:389–97.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice;Precision Medicine and Engineering;2024-09

2. NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer;Breast Cancer Research;2024-04-22

3. Impact of Resistance on Therapeutic Design: A Moran Model of Cancer Growth;Bulletin of Mathematical Biology;2024-03-19

4. In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla;International Journal of Molecular Sciences;2024-01-31

5. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice;Medicina;2024-01-17